Parecer de pré-exame
#6.23
07/16/2024
RPI 2793
Application data
Number
112021018308Type
Filing
Publication
PCT
EP2020056799 The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.
Latest action published by the INPI: 07/16/2024. We update with every new RPI gazette, published weekly.
Applicants
LO.LI. PHARMA S.R.L.
IT
Inventors
V. U. (pessoa física)
IT
IPC Classification
Priority claims
IT
102019000003843 · 03/15/2019
Abstract
A presente invenção se refere ao uso de vitamina D e um agente selecionado a partir do grupo consistindo de: epigalocatequina galato (EGCG), catequina, galocatequina e epicatequina galato (ECG), para a prevenção, controle e/ou tratamento de fibromas em um indivíduo.
Publications in the Brazilian Industrial Property Gazette (RPI).
#6.23
07/16/2024
RPI 2793
#1.3
11/23/2021
RPI 2655
#1.1
09/28/2021
RPI 2647
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.